Company: AILIM
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001002910-25-000112
Chunk: 149

Company: Ameren Illinois Co
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 149
---
 or, in the case of Ameren Missouri and Ameren Illinois, with capital contributions from Ameren (parent). As of June 30, 2025, there have been no material changes other than in the ordinary course of business related to cash requirements arising from the long-term commitments for fuel for generation, purchased power, and natural gas for distribution as described under Liquidity and Capital Resources in Item 7 of the Form 10-K.

We expect to make significant capital expenditures over the next five years, supported by a combination of long-term debt and equity, as we invest in our electric and natural gas utility infrastructure to support overall system reliability, grid modernization, renewable energy target requirements, environmental compliance, and other improvements. For additional information about our long-term debt outstanding, including maturities due within one year, and the applicable interest rates, see Note 5 – Long-term Debt and Equity Financings under Part II, Item 8 of the Form 10-K and Note 4 – Long-term Debt and Equity Financings under Part I, Item 1, of this report. As part of its funding plan for capital expenditures, Ameren is using newly-issued shares of common stock to satisfy requirements under the DRPlus and employee benefit plans 

63

and expects to continue to do so through at least 2029. Additionally, Ameren may offer and sell from time to time common stock, including under its ATM program, which includes the ability to enter into forward sale agreements, subject to market conditions and other factors. There were no shares issued under the ATM program during the six months ended June 30, 2025. As of June 30, 2025, Ameren had multiple forward sale agreements that could be settled with various counterparties relating to 12.2 million shares of common stock. Ameren expects to settle approximately $530 million of the forward sale agreements with physical delivery of 5.8 million shares of common stock by December 31, 2025 and to settle another approximately $590 million of the forward sale agreements with physical delivery of 6.4 million shares of common stock by December 31, 2026. Including issuances under the DRPlus and employee benefit plans, Ameren plans to issue approximately $600 million of equity each year from 2025 to 2029. As of June 30, 2025, Ameren had approximately $230 million of common stock available for sale under the ATM program, which takes